Public Health & Environment Committee — Nov 5, 2025: Buprenorphine hearing held; Naloxone resolution recommended favorably

CALL TO ORDER

INTRODUCTIONS

ATTENDANCE

ITEMS SCHEDULED FOR PUBLIC HEARING

Emergency Medical Services – Administration of Buprenorphine FOR the purpose of requiring Baltimore City Emergency Medical Services to provide buprenorphine to all Emergency Medical Services technicians; allowing Emergency Medical Services technicians to administer buprenorphine to an individual under certain circumstances; and defining certain terms.

Informational Hearing - Availability of Naloxone in Public Buildings FOR the purpose of requiring the City Administrator, Commissioner of the Baltimore Health Department, and the Director of the Department of General Services to appear before the City Council to present an assessment of the City’s readiness to comply with the provisions of Chapter 764 of the Acts of the Maryland General Assembly of 2024, “Emergency Services – Automated External Defibrillator and Naloxone Co-Location Initiative – Requirements for Public Buildings”, by updating its health and safety protocols for all City buildings.

ADJOURNMENT

THIS MEETING IS OPEN TO THE PUBLIC